University of Iowa
Pediatric Hematology-Oncology fellowship · Iowa City, IA · Program website
Pediatrics residency here · Other fellowships: Neonatal-Perinatal Medicine · Pediatric Cardiology · Pediatric Critical Care Medicine · Pediatric Gastroenterology · Pediatric Pulmonology · Pediatric Endocrinology · Pediatric Nephrology
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is University of Iowa's research in pediatric hematology-oncology, which the program shares with other departments and affiliated hospitals.
Pediatric Hematology-Oncology at University of Iowashared by every program there, not this program's own
Institution-level: all pediatric hematology-oncology publications from University of Iowa and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
Works per year · * 2026 so far
Pediatric Hematology-Oncology research topics at University of Iowa
Papers in the window; each links to the list on OpenAlex.
- Neuroendocrine Tumor Research Advances 106
- Cancer Immunotherapy and Biomarkers 100
- Glioma Diagnosis and Treatment 66
- Pancreatic and Hepatic Oncology Research 63
- CAR-T cell therapy research 63
- Multiple Myeloma Research and Treatments 61
- Sarcoma Diagnosis and Treatment 58
- Global Cancer Incidence and Screening 54
Most cited at University of Iowa since 2024
All pediatric hematology-oncology papers there on OpenAlex
- Menin Inhibition With Revumenib for KMT2A -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)Ghayas C. Issa et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 262
- JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphomaJaroslav Žák et al. · Science · 2024 · PubMed · cited 204
- The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney TransplantationCamille N. Kotton et al. · Transplantation · 2024 · PubMed · cited 195
- Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancerMargherita Ambrosini et al. · Annals of Oncology · 2024 · PubMed · cited 112
- Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trialYvonne Marie Mowery et al. · The Lancet · 2024 · PubMed · cited 102
- Revolutionizing cancer treatment: comprehensive insights into immunotherapeutic strategiesNeha R. Raghani et al. · Medical Oncology · 2024 · PubMed · cited 93
- Menin inhibition with revumenib for NPM1 -mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 studyMartha Lucia Arellano et al. · Blood · 2025 · PubMed · cited 86
- Trends in childhood cancer: Incidence and survival analysis over 45 years of SEER dataIyad Yasin Sultan et al. · PLoS ONE · 2025 · PubMed · cited 83
- Long‐term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM‐3 studyMichael H. Tomasson et al. · HemaSphere · 2024 · PubMed · cited 75
- RP1 Combined With Nivolumab in Advanced Anti–PD-1–Failed Melanoma (IGNYTE)Michael K. Wong et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 60
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/university-iowa-peds-heme-onc"><img src="https://openprograms.org/programs/university-iowa-peds-heme-onc/badge.svg" alt="University of Iowa Pediatric Hematology-Oncology fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.